Ubs Group Ag Sab Biotherapeutics Inc Wt Exp Transaction History

Ubs Group Ag

  • $527 Billion
  • Q4 2024

A detailed history of Ubs Group Ag transactions in Sab Biotherapeutics Inc Wt Exp stock. As of the latest transaction made, Ubs Group Ag holds 1,633 shares of SABSW stock, worth $48. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,633
Holding current value
$48
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$0.03 - $0.1 $48 - $163
1,633 New
1,633 $0
Q2 2024

Aug 13, 2024
BUY
$0.02 - $0.07 $1 - $3
56 New
56 $0
Q4 2023

Feb 09, 2024
BUY
$0.03 - $0.1 $872 - $2,908
29,080 New
29,080 $0
Q2 2023

Aug 11, 2023
BUY
$0.04 - $0.16 $4 - $16
100 New
100 $0
Q3 2022

Nov 10, 2022
BUY
$0.05 - $0.22 $280 - $1,233
5,606 New
5,606 $0
Q1 2022

May 16, 2022
SELL
$0.22 - $1.87 $635 - $5,400
-2,888 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$0.95 - $3.0 $2,743 - $8,664
2,888 New
2,888 $5,000

Others Institutions Holding SABSW

# of Institutions
11
Shares Held
879K
Call Options Held
62.5K
Put Options Held
0
View Full List

About SAB BIOTHERAPEUTICS INC WT EXP

SABSW Quotes by TradingView
  • Ticker SABSW
  • Sector Healthcare
  • Industry Biotechnology
More about SABSW
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email